FDA website to post names of drug makers blocking development of cheaper generics

The FDA plans to unveil a website today naming pharmaceutical companies that have blocked the development of generic drugs by failing to provide samples to competitors. This public posting is part of FDA Commissioner Scott Gottlieb’s larger crackdown to, as he says, “end the shenanigans” by brand name drug companies.

Click the audio player above to hear the full story.

Follow Dan Gorenstein at @dmgorenstein

Source link

Leave a Reply

Your email address will not be published.